微信公众号
证券之星APP
| 报告期 | 净资产收益率 | 同比 | 环比 | 行业排名 | 行业均值 | 行业龙头股 | 龙头股该指标值 | 查看 |
|---|---|---|---|---|---|---|---|---|
| 2025-09-30 | 0.69% | -57.41% | 32.69% | 103/159 | 1.2% | 兴齐眼药 | 32.91% | 行业排名> |
| 2025-06-30 | 0.52% | -27.78% | 173.68% | 100/159 | 0.26% | 翰宇药业 | 18.95% | 行业排名> |
| 2025-03-31 | 0.19% | -74.67% | -17.39% | 105/159 | -0.37% | 翰宇药业 | 11.39% | 行业排名> |
| 2024-12-31 | 0.23% | 131.51% | -85.8% | 101/159 | -9.52% | 百利天恒 | 181.27% | 行业排名> |
| 2024-09-30 | 1.62% | 252.17% | 125% | 102/159 | 4.23% | 百利天恒 | 186.1% | 行业排名> |
| 2024-06-30 | 0.72% | 89.47% | -4% | 106/159 | 2.66% | 百利天恒 | 186.89% | 行业排名> |
| 2024-03-31 | 0.75% | 247.06% | 202.74% | 98/159 | 2.32% | 百利天恒 | 188.56% | 行业排名> |
| 2023-12-31 | -0.73% | 77.33% | -258.7% | 106/159 | -1.03% | 小方制药 | 41.8% | 行业排名> |
| 2023-09-30 | 0.46% | -51.58% | 21.05% | 114/159 | 2.34% | 拓新药业 | 20.51% | 行业排名> |
| 2023-06-30 | 0.38% | 124.05% | 174.51% | 111/159 | 1.46% | 拓新药业 | 19.87% | 行业排名> |
| 2023-03-31 | -0.51% | 55.26% | 84.16% | 123/159 | 1.37% | 拓新药业 | 19.91% | 行业排名> |
| 2022-12-31 | -3.22% | 30.3% | -438.95% | 115/159 | 0.67% | 小方制药 | 55.57% | 行业排名> |
| 2022-09-30 | 0.95% | -59.92% | 160.13% | 107/159 | 2.8% | 福元医药 | 25.41% | 行业排名> |
| 2022-06-30 | -1.58% | -187.78% | -38.6% | 120/159 | 2.16% | 小方制药 | 34.81% | 行业排名> |
| 2022-03-31 | -1.14% | -234.12% | 75.32% | 123/159 | 1.57% | 退市金泰 | 10.74% | 行业排名> |
| 2021-12-31 | -4.62% | -212.41% | -294.94% | 120/159 | 0.75% | 人福医药 | 6.82% | 行业排名> |
| 2021-09-30 | 2.37% | -37.63% | 31.67% | 101/159 | 4.43% | 小方制药 | 71.99% | 行业排名> |
| 2021-06-30 | 1.8% | -10.45% | 111.76% | 100/159 | 2.94% | 汇宇制药 | 39.25% | 行业排名> |
| 2021-03-31 | 0.85% | 11.84% | -79.32% | 98/159 | 2.49% | 汇宇制药 | 28.14% | 行业排名> |
| 2020-12-31 | 4.11% | -4.86% | 8.16% | 91/159 | 3.58% | 哈三联 | 27.17% | 行业排名> |
| 2020-09-30 | 3.8% | 0.53% | 89.05% | 79/159 | 3.03% | 汇宇制药 | 55.94% | 行业排名> |
| 2020-06-30 | 2.01% | 81.08% | 164.47% | 86/159 | 4.19% | 河化股份 | 45.32% | 行业排名> |
| 2020-03-31 | 0.76% | 189.41% | -82.41% | 74/159 | 2.19% | 汇宇制药 | 31.9% | 行业排名> |
| 2019-12-31 | 4.32% | 74.19% | 14.29% | 91/159 | 2.53% | 誉衡药业 | 35.56% | 行业排名> |
| 2019-09-30 | 3.78% | 0% | 240.54% | 78/159 | 7.48% | 奥赛康 | 35% | 行业排名> |
| 2019-06-30 | 1.11% | -6.72% | 230.59% | 96/159 | 4.96% | 奥赛康 | 28.15% | 行业排名> |
| 2019-03-31 | -0.85% | -244.07% | -134.27% | 102/159 | 2.41% | 宏源药业 | 21.91% | 行业排名> |
| 2018-12-31 | 2.48% | -20% | -34.39% | 105/159 | 6.99% | 奥赛康 | 9.7% | 行业排名> |
| 2018-09-30 | 3.78% | 66.52% | 217.65% | 80/159 | 7.18% | 奥赛康 | 40.69% | 行业排名> |
| 2018-06-30 | 1.19% | 5.31% | 101.69% | 94/159 | 4.6% | 信立泰 | 25.93% | 行业排名> |
| 2018-03-31 | 0.59% | 1.72% | -80.97% | 88/159 | 2.54% | 昂利康 | 15.91% | 行业排名> |
| 2017-12-31 | 3.1% | -47.64% | 36.56% | 99/159 | 9.61% | 奥赛康 | 12.08% | 行业排名> |
| 2017-09-30 | 2.27% | -48.53% | 100.89% | 85/159 | 8.29% | 一品红 | 31.62% | 行业排名> |
| 2017-06-30 | 1.13% | -45.93% | 94.83% | 92/159 | 5.58% | 丽珠集团 | 49.43% | 行业排名> |
| 2017-03-31 | 0.58% | -29.27% | -90.2% | 74/159 | 2.09% | 河化股份 | 54.24% | 行业排名> |
| 2016-12-31 | 5.92% | -36.55% | 34.24% | 76/159 | 6.19% | 华东医药 | 7.2% | 行业排名> |
| 2016-09-30 | 4.41% | -34.08% | 111% | 55/159 | 5.61% | 南新制药 | 81.7% | 行业排名> |
| 2016-06-30 | 2.09% | -37.05% | 154.88% | 67/159 | 3.48% | 德展健康 | 29.5% | 行业排名> |
| 2016-03-31 | 0.82% | 1.23% | -91.21% | 60/159 | 2.65% | 贝达药业 | 16.78% | 行业排名> |
| 2015-12-31 | 9.33% | -19.64% | 39.46% | 53/159 | 11.27% | 河化股份 | 19.29% | 行业排名> |
| 2015-09-30 | 6.69% | -18.32% | 101.51% | 39/159 | 7.22% | 一品红 | 58.17% | 行业排名> |
| 2015-06-30 | 3.32% | -22.97% | 309.88% | 52/159 | 4.87% | 华东医药 | 36.97% | 行业排名> |
| 2015-03-31 | 0.81% | -63.84% | -93.02% | 53/159 | 2.41% | 华东医药 | 26.63% | 行业排名> |